Andy Stylianou helps clients to understand the legal issues in corporate transactions and deal with them commercially.
With more than 20 years' experience in mergers and acquisitions, and as a specialist private equity lawyer, corporate partner Andy certainly has 'the knowledge'. He leads from the front, taking a hands-on approach to deals and guiding his clients smoothly through the transaction process.
What keeps him keen is being part of the client's team - living and breathing their business on every transaction. Each client is different, but there are similar concerns and passions involved in any M&A transaction. Ultimately it's about growing the business. It's important to understand what the client wants to achieve, and then get stuck in to make sure we do everything possible to achieve this. He likes to share the client's 'dream'.
One highlight was taking Equiom to the next stage by advising on the secondary buy-out from Livingbridge to LDC in 2013. Andy has since continued to work alongside a great team who have an international vision with a 'buy and build' strategy, acquiring businesses in Hong Kong and Guernsey and additional businesses in Jersey and the Isle of Man.
Advising CBPE and management of the £183m disposal of Rosemont Pharmaceuticals to US$10bn US-listed pharmaceuticals giant, Perrigo. The strength of the firm's team across numerous specialist areas and the close relationship with CBPE, Rosemont and the Rosemont management team ensured that the firm could deliver a smooth transaction within complex commercial circumstances.
August Equity Partners LLP, Away Resorts Limited, CBPE Capital LLP, Connect Group plc and its subsidiaries, Entanet International Limited, Equiom Holdings Limited and its subsidiaries, Fisher Outdoor Leisure Holdings Limited, Livingbridge, LDC, Medica Reporting Group, Melbourn Pharmaceuticals, Mobeus Equity Partners LLP.
After advising CBPE Capital LLP on its acquisition of and investment in Rosemont Pharmaceuticals in 2006, Andy led the Wragge & Co team advising CBPE Capital and management on the subsequent £183m sale of Rosemont to US-listed pharmaceuticals giant, Perrigo. With Andy's long relationship with CBPE Capital and Rosemont Pharmaceuticals, the transaction was an excellent fit for the firm.
Acting for the FTSE-listed Connect Group plc on various acquisitions and disposals and large commercial contracts. Andy also worked with Connect Group plc on its name change from Smiths News plc earlier this year.
Working with the firm's other healthcare experts, Andy led and advised CBPE Capital and management on the acquisition of Medica Reporting Limited from Nuffield Health Group. Medica is the UK's leading provider of high quality teleradiology reporting services and operator of the country's largest remote radiology reporting network.
Relying on his private equity expertise, in 2006 ISIS Equity Partners instructed Andy to advise them on their investment to fund the acquisition of Isle of Man-based Equiom Group from Anglo Irish Bank. Following the investment, Andy was instructed by Equiom as the group's legal adviser and he, with the Wragge Lawrence Graham & Co team, advised them on a number of international acquisitions and partnerships, including the acquisition from InterTrust and, the acquisition of Jersey based Andium Trust Company Limited.
As trusted advisor, in 2013 Andy led the team advising ISIS Equity Partners and management on the secondary buy out of Equiom to LDC and management. Following the secondary buy-out, Andy and the team advised Equiom on the acquisition of Isle of Man-based West Corporation.
With his M&A and private equity expertise, Andy advised CBPE Capital on its investment in Away Resorts Limited, a CBPE investee company and caravan park operator, on its acquisition of Whitecliff Bay, Tattershall Lakes, Mill Rythe and Barmouth Bay.